Voyager Therapeutics: 3Q Earnings Snapshot

November 6, 2019 GMT

CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Wednesday reported a loss of $15 million in its third quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 41 cents.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.

The gene therapy company posted revenue of $20.4 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $3.9 million.

Voyager Therapeutics shares have risen 58% since the beginning of the year. The stock has risen 5.5% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR